Questions about the durability of an experimental Huntington's disease therapy matter to Wall Street. They matter less to those directly affected by the disease.
Back to Lifestyle
Lifestyle
October 1, 2026 at 10:30 AM
STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy
STAT News
Excerpt from STAT News.